Favorable outcomes with alemtuzumab-conditioned unrelated donor stem cell transplantation in adults with high-risk Philadelphia chromosome-negative acute lymphoblastic leukemia in first complete remission

BACKGROUND: Approximately 40% of adults with Philadelphia chromosome-negative acute lymphoblastic leukemia achieve long-term survival following unrelated donor hematopoietic stem cell transplantation in first complete remission but severe graft-versus-host disease remains a problem affecting surviva...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Patel, Bella, Kirkland, Keiren E., Szydlo, Richard, Pearce, Rachel M., Clark, Richard E., Craddock, Charles, Liakopoulou, Effie, Fielding, Adele K., Mackinnon, Stephen, Olavarria, Eduardo, Potter, Mike N., Russell, Nigel H., Shaw, Bronwen E., Cook, Gordon, Goldstone, Anthony H., Marks, David I.
Formato: Artigo
Idioma:Inglês
Publicado: Ferrata Storti Foundation 2009
Assuntos:
Original Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2754956/
https://ncbi.nlm.nih.gov/pubmed/19648167
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2009.008649
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares